To test whether GYZ induces anoikis in NSCLC cells, we found that the protein level of Integrin β3, Bcl-2 and Caveloin-1 were obviously decreased after GYZ treatment in A549 and H1975 cells (Figure 2E). The gene discussed is BCL2; the disease is non-small cell lung carcinoma.